[1] |
SIEGEL R L, MILLER K D, JEMAL A. Cancer statistics,2020[J]. CA Cancer J Clin, 2020, 70(1):7-30.
DOI
URL
|
[2] |
LIU X, YU C, BI Y, et al. Trends and age-period-cohort effect on incidence and mortality of prostate cancer from 1990 to 2017 in China[J]. Public Health, 2019, 172:70-80.
DOI
URL
|
[3] |
PODDER T K, FREDMAN E T, ELLIS R J. Advances in radiotherapy for prostate cancer treatment[J]. Adv Exp Med Biol, 2018, 1096:31-47.
|
[4] |
SUN H, FAN G, DENG C, et al. MiR-4429 sensitized cervical cancer cells to irradiation by targeting RAD51[J]. J Cell Physiol, 2020, 235(1):185-193.
DOI
URL
|
[5] |
LIU X, CHEN R, LIU L. SP1-DLEU1-miR-4429 feedback loop promotes cell proliferative and anti-apoptotic abilities in human glioblastoma[J]. Biosci Rep, 2019,39(12):BSR20190994.
|
[6] |
HE H, WU W, SUN Z, et al. MiR-4429 prevented gastric cancer progression through targeting METTL3 to inhibit m6A-caused stabilization of SEC62[J]. Biochem Biophys Res Commun, 2019, 517(4):581-587.
DOI
URL
|
[7] |
WU W J, YIN H, HU J J, et al. Long noncoding RNA LINC00313 modulates papillary thyroid cancer tumorigenesis via sponging miR-4429[J]. Neoplasma, 2018, 65(6):933-942.
DOI
URL
|
[8] |
TONG L, CHU M, YAN B, et al. MTDH promotes glioma invasion through regulating miR-130b-ceRNAs[J]. Oncotarget, 2017, 8(11):17738-17749.
DOI
URL
|
[9] |
KPÜGER J, REHMSMEIER M, RNAgybrid:microRNA target prediction easy,fast and flexible[J]. Nucleic Acids Res, 2006, 34(Web Server issue):W451-W454.
DOI
URL
|
[10] |
PAN H, HONG Y, YU B, et al. MiR-4429 inhibits tumor progression and epithelial-mesenchymal transition via targeting CDK6 in clear cell renal cell carcinoma[J]. Cancer Biother Radiopharm, 2019, 34(5):334-341.
|
[11] |
DONG R, SHEN Z, ZHENG C, et al. Serum microRNA microarray analysis identifies miR-4429 and miR-4689 are potential diagnostic biomarkers for biliary atresia[J]. Sci Rep, 2016, 6:21084.
DOI
URL
|
[12] |
JICKLING G C, ANDER B P, ZHAN X, et al. MicroRNA expression in peripheral blood cells following acute ischemic stroke and their predicted gene targets[J]. PLoS One, 2014, 9(6):e99283.
DOI
URL
|
[13] |
LIU D, HUANG K, WANG T, et al. NR2F2-AS1 accelerates cell proliferation through regulating miR-4429/MBD1 axis in cervical cancer[J]. Biosci Rep, 2020,40(6):BSR20194282.
|
[14] |
HE A, HE S, HUANG C, et al. MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition[J]. Aging(Albany NY), 2020, 12(2):1465-1487.
|
[15] |
CHEN J, JIA Y, JIA Z H, et al. Silencing the expression of MTDH increases the radiation sensitivity of SKOV3 ovarian cancer cells and reduces their proliferation and metastasis[J]. Int J Oncol, 2018, 53(5):2180-2190.
|
[16] |
JIN Y, ZHANG Z L, HUANG Y, et al. MiR-182-5p inhibited proliferation and metastasis of colorectal cancer by targeting MTDH[J]. Eur Rev Med Pharmacol Sci, 2019, 23(4):1494-1501.
|
[17] |
QIAO W, CAO N, YANG L. MicroRNA-154 inhibits the growth and metastasis of gastric cancer cells by directly targeting MTDH[J]. Oncol Lett, 2017, 14(3):3268-3274.
DOI
URL
|